{"article_title": "Veteran Investor Sam Isaly Picks Top Biotech Stocks", "article_keywords": ["biotech", "sam", "isaly", "veteran", "picks", "stocks", "investor"], "article_url": "http://www.barrons.com/articles/veteran-investor-sam-isaly-picks-top-biotech-stocks-1435060100", "article_text": "", "article_metadata": {"article.template": "snippet", "article.created": "2015-06-23T11:48:00.000Z", "lifp_basePath": "https://id.barrons.com/access", "page.region": "na,us", "page.content.type": "Article", "twitter": {"image": {"src": "https://si.wsj.net/public/resources/images/ON-BL150_SamIsa_G_20150618144825.jpg", "alt": "Veteran Investor Sam Isaly Picks Top Biotech Stocks", "identifier": "https://si.wsj.net/public/resources/images/ON-BL150_SamIsa_D_20150618144825.jpg"}, "description": "The Eaton Vance Worldwide Health Sciences fund favors big biotechs like Regeneron, AbbVie and Biogen.", "card": "summary_large_image", "title": "Veteran Investor Sam Isaly Picks Top Biotech Stocks"}, "page.site.product": "WSJ", "keywords": "AbbVie,ABBV,Bristol-Myers Squibb,BMY,Eaton Vance,EV,Regeneron Pharmaceuticals,REGN,political,general news,personal investments in mutual funds,personal finance,personal investments,equity markets,commodity,financial market news,pharmaceuticals,financial investments,investment advice,health care,life sciences,financial services,investing,securities,medical research services,healthcare support services,medical,clinical,diagnostic services", "news_keywords": "AbbVie,ABBV,Bristol-Myers Squibb,BMY,Eaton Vance,EV,Regeneron Pharmaceuticals,REGN,political,general news", "article.headline": "Veteran Investor Sam Isaly Picks Top Biotech Stocks", "description": "The Eaton Vance Worldwide Health Sciences fund favors big biotechs like Regeneron, AbbVie and Biogen.", "apple-itunes-app": "app-id=409882593,app-argument=barrons://launch?articleid=SB50913253595190813616304581056241759937346&headline=Veteran%20Investor%20Sam%20Isaly%20Picks%20Top%20Biotech%20Stocks&weburl=http://www.barrons.com/articles/SB50913253595190813616304581056241759937346", "user.type": "nonsubscriber", "article.page": "Weekday", "article.section": "Home", "article.summary": "The Eaton Vance Worldwide Health Sciences fund favors big biotechs like Regeneron, AbbVie and Biogen.", "page.site": "barrons", "testkeys": "A", "article.published": "2015-06-23T04:01:00.000Z", "dj.asn": "i-e969", "robots": "noarchive,noodp", "fb": {"app_id": 143538339355}, "article": {"internal_link_count": 4, "embed_count": 4, "word_count": 1560}, "viewport": "width=device-width, user-scalable=yes, target-densitydpi=160", "page.section": "Article", "language": "en-US", "og": {"description": "The Eaton Vance Worldwide Health Sciences fund favors big biotechs like Regeneron, AbbVie and Biogen.", "title": "Veteran Investor Sam Isaly Picks Top Biotech Stocks", "url": "http://www.barrons.com/articles/veteran-investor-sam-isaly-picks-top-biotech-stocks-1435060100", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/ON-BL150_SamIsa_G_20150618144825.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Johanna Bennett", "article.access": "paid", "page.content.source": "Barron's Online", "article.origheadline": "Veteran Investor Sam Isaly Picks Top Biotech Stocks", "article.type": "Electronic Q&A", "article.id": "SB50913253595190813616304581056241759937346", "user.exp": "default", "article.updated": "2015-06-23T04:01:00.000Z"}, "_id": "\"57477af36914bd0286fcaa46\"", "article_summary": ""}